Results 231 to 240 of about 600,571 (264)

Balancing Stealth and Targetability: cCPP‐ and PEG‐Modified Liposomes for the Targeted Delivery of Anti‐HER2 Nanobodies

open access: yesAdvanced Science, EarlyView.
This study addresses the rapid renal clearance of anti‐HER2 nanobodies by developing specialized liposomal carriers. It details the formulation of dual modified liposomes, demonstrating how PEGylation preserves structural integrity and cell‐penetrating peptides enhance cellular interaction.
Giulia Pander   +14 more
wiley   +1 more source

A Plug‐and‐Play Platform for Customizing Multivalent Degraders and Degrader‐Drug Conjugates

open access: yesAdvanced Science, EarlyView.
Membrane proteins remain challenging targets for conventional TPD approaches. Here, the authors develop UPTAB, a modular platform leveraging ultrahigh‐affinity orthogonal Im/CL protein pairs for lysosomal degradation of membrane proteins. Mono‐targeted (Type‐I), dual‐targeted (Type‐II), and tri‐targeted (Type‐III) UPTABs enable simultaneous degradation
Mengqing Zhao   +7 more
wiley   +1 more source

Accurate and Scalable Classification of Colonoscopy Neoplasia Using Machine Learning and Natural Language Processing. [PDF]

open access: yesClin Transl Gastroenterol
Broderick B   +8 more
europepmc   +1 more source

Linking subjective experience of anxiety to brain function using natural language processing. [PDF]

open access: yesSoc Cogn Affect Neurosci
Kirk PA   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy